Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
12768504 |
Age 32.6 ± 4.4 , Gender ♀ |
29.0 (μmol/l) |
LC |
blood |
12768504 |
Age 48 ± 4.3, Gender ♀ |
18.0 (μmol/l) |
LC |
blood |
12768504 |
Age 74.7 ± 10, Gender ♀ |
16.0 (μmol/l) |
LC |
blood |
12768504 |
Age 33.3 ± 3.8, Gender ♂ |
21.0 (μmol/l) |
LC |
blood |
12768504 |
Age 48.4 ± 6, Gender ♂ |
17.0 (μmol/l) |
LC |
blood |
12768504 |
Age 75.9 ± 9.3, Gender ♂ |
13.0 (μmol/l) |
LC |
blood |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.967708 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.197744 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
23838602 |
Age [17–85], Gender ⚥ |
-0.006 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
-1.05 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
-0.92 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
-0.81 (β) |
UHPLC/MS/MS |
serum and plasma |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |